Literature DB >> 25118603

Hepatocellular carcinoma: gender differences.

Sarah Seton-Rogers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25118603     DOI： 10.1038/nrc3808

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice.

Authors:  Hadley J Hartwell; Keiko Y Petrosky; James G Fox; Nelson D Horseman; Arlin B Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205
  1 in total
  7 in total

1.  STAT5 Regulation of Sex-Dependent Hepatic CpG Methylation at Distal Regulatory Elements Mapping to Sex-Biased Genes.

Authors:  Pengying Hao; David J Waxman
Journal:  Mol Cell Biol       Date:  2021-01-25       Impact factor: 4.272

2.  Sexually Dimorphic Expression of eGFP Transgene in the Akr1A1 Locus of Mouse Liver Regulated by Sex Hormone-Related Epigenetic Remodeling.

Authors:  Cheng-Wei Lai; Hsiao-Ling Chen; Tung-Chou Tsai; Te-Wei Chu; Shang-Hsun Yang; Kowit-Yu Chong; Chuan-Mu Chen
Journal:  Sci Rep       Date:  2016-04-18       Impact factor: 4.379

3.  Sex-dependent liver cancer xenograft models for predicting clinical data in the evaluation of anticancer drugs.

Authors:  Sungryong Oh; Joohee Jung
Journal:  Lab Anim Res       Date:  2021-02-25

4.  Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells.

Authors:  Hsueh-Chou Lai; Chun-Chieh Yeh; Long-Bin Jeng; Shang-Fen Huang; Pei-Ying Liao; Fu-Ju Lei; Wei-Chun Cheng; Cheng-Lung Hsu; Xiujun Cai; Chawnshang Chang; Wen-Lung Ma
Journal:  Oncotarget       Date:  2016-07-19

Review 5.  Blood glucose concentration and risk of liver cancer: systematic review and meta-analysis of prospective studies.

Authors:  Hedong Han; Tianyi Zhang; Zhichao Jin; Honglei Guo; Xin Wei; Yuzhou Liu; Qi Chen; Jia He
Journal:  Oncotarget       Date:  2017-07-25

6.  Butein Inhibited In Vitro Hexokinase-2-Mediated Tumor Glycolysis in Hepatocellular Carcinoma by Blocking Epidermal Growth Factor Receptor (EGFR).

Authors:  Weirong Liao; Jingtian Liu; Dawei Zhang; Wenhai Huang; Runhao Chen
Journal:  Med Sci Monit       Date:  2018-05-19

7.  Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma.

Authors:  Ping Li; YanZhen Xu; Qinle Zhang; Yu Li; Wenxian Jia; Xiao Wang; Zhibin Xie; Jiayi Liu; Dong Zhao; Mengnan Shao; Suixia Chen; Nanfang Mo; Zhiwen Jiang; Liuyan Li; Run Liu; Wanying Huang; Li Chang; Siyu Chen; Hongtao Li; Wenpu Zuo; Jiaquan Li; Ruoheng Zhang; Xiaoli Yang
Journal:  Cancer Cell Int       Date:  2019-11-06       Impact factor: 5.722
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.